Your browser doesn't support javascript.
loading
A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome.
Lacout, Catherine; Haddad, Elie; Sabri, Siham; Svinarchouk, Fedor; Garçon, Loic; Capron, Claude; Foudi, Adlen; Mzali, Rym; Snapper, Scott B; Louache, Fawzia; Vainchenker, William; Duménil, Dominique.
Afiliação
  • Lacout C; U362 Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Gustave Roussy, Villejuif, France.
Blood ; 102(4): 1282-9, 2003 Aug 15.
Article em En | MEDLINE | ID: mdl-12730112
ABSTRACT
A defect in cell trafficking and chemotaxis plays an important role in the immune deficiency observed in Wiskott-Aldrich syndrome (WAS). In this report, we show that marrow cells from WAS protein (WASP)-deficient mice also have a defect in chemotaxis. Serial transplantation and competitive reconstitution experiments demonstrated that marrow cells, including hematopoietic progenitors and stem cells (HSCs), have decreased homing capacities that were associated with a defect in adhesion to collagen. During development, HSCs migrate from the liver to the marrow and the spleen, prompting us to ask if a defect in HSC homing during development may explain the skewed X-chromosome inactivation in WAS carriers. Preliminary evidence has shown that, in contrast to marrow progenitor cells, fetal liver progenitor cells from heterozygous females had a random X-chromosome inactivation. When fetal liver cells from WASP-carrier females were injected into irradiated recipients, a nonrandom inactivation of the X-chromosome was found at the level of hematopoietic progenitors and HSCs responsible for the short- and long-term hematopoietic reconstitution. Therefore, the mechanism of the skewed X-chromosomal inactivation observed in WAS carriers may be related to a migration defect of WASP-deficient HSCs.
Assuntos
Buscar no Google
Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Síndrome de Wiskott-Aldrich / Células-Tronco Hematopoéticas / Proteínas / Quimiotaxia / Mecanismo Genético de Compensação de Dose Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Síndrome de Wiskott-Aldrich / Células-Tronco Hematopoéticas / Proteínas / Quimiotaxia / Mecanismo Genético de Compensação de Dose Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2003 Tipo de documento: Article